BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24521767)

  • 21. The myocarditis of systemic lupus erythematosus: association with myositis.
    Borenstein DG; Fye WB; Arnett FC; Stevens MB
    Ann Intern Med; 1978 Nov; 89(5 Pt 1):619-24. PubMed ID: 717930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous immunoglobulin for immunomodulation of systemic lupus erythematosus.
    Sherer Y; Shoenfeld Y
    Autoimmun Rev; 2006 Feb; 5(2):153-5. PubMed ID: 16431350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lupus myopathy refractory to steroid treatment].
    González-Gay MA; Fernández Camblor B; Agüero JJ; Villarino MJ; Eiriz M; Mata I
    An Med Interna; 1991 Oct; 8(10):501-2. PubMed ID: 1751691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small muscle myositis in a patient with systemic lupus erythematosus successfully treated with rituximab.
    Hui M; Andres M; Latief K; Courtney P
    Lupus; 2011 Oct; 20(12):1340-1. PubMed ID: 21768178
    [No Abstract]   [Full Text] [Related]  

  • 25. Concurrent onset of acute lupus myocarditis, pulmonary arterial hypertension and digital gangrene in a lupus patient: a possible role of vasculitis to the rare disorders.
    Ando T; Yamasaki Y; Takakuwa Y; Iida H; Asari Y; Suzuki K; Uchida M; Kotoku N; Tanabe Y; Chosokabe M; Takahashi M; Suzuki K; Akashi YJ; Yamada H; Kawahata K
    Mod Rheumatol Case Rep; 2020 Jan; 4(1):21-27. PubMed ID: 33086967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of Evans syndrome combined with systemic lupus erythematosus successfully treated with rituximab.
    Kittaka K; Dobashi H; Baba N; Iseki K; Kameda T; Susaki K; Kitanaka A; Kubota Y; Ishida T
    Scand J Rheumatol; 2008; 37(5):390-3. PubMed ID: 18609263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of systemic lupus erythematosus by prolonged administration of high dose intravenous immunoglobulin: report of 2 cases.
    Winder A; Molad Y; Ostfeld I; Kenet G; Pinkhas J; Sidi Y
    J Rheumatol; 1993 Mar; 20(3):495-8. PubMed ID: 8478856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Newer therapeutic approaches for systemic lupus erythematosus: immunosuppressive agents.
    Dooley MA; Ginzler EM
    Rheum Dis Clin North Am; 2006 Feb; 32(1):91-102, ix. PubMed ID: 16504823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute lupus myocarditis: Clinical features and outcome.
    Appenzeller S; Pineau CA; Clarke AE
    Lupus; 2011 Aug; 20(9):981-8. PubMed ID: 21478290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxic epidermal necrolysis in systemic lupus erythematosus.
    Horne NS; Narayan AR; Young RM; Frieri M
    Autoimmun Rev; 2006 Feb; 5(2):160-4. PubMed ID: 16431352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical applications of immunoglobulin in neuromuscular diseases: focus on inflammatory myopathies.
    Souza PV; Pinto WB; Oliveira AS
    Arq Neuropsiquiatr; 2014 Dec; 72(12):966-71. PubMed ID: 25465778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous immunoglobulin for recalcitrant subacute cutaneous lupus erythematosus.
    Kreuter A; Hyun J; Altmeyer P; Gambichler T
    Acta Derm Venereol; 2005; 85(6):545-7. PubMed ID: 16396813
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment with intravenous immunoglobulin in pure red cell aplasia in patient wtih systemic lupus erythematosus].
    Casado Burgos E; Navarro T; Olivé A; Ribera JM
    Med Clin (Barc); 1999 May; 112(17):678. PubMed ID: 10374194
    [No Abstract]   [Full Text] [Related]  

  • 34. Myocarditis in a girl as an initial manifestation of systemic lupus erythematosus.
    Mercado U; Muñoz LL
    Clin Exp Rheumatol; 2005; 23(2):280. PubMed ID: 15895912
    [No Abstract]   [Full Text] [Related]  

  • 35. Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus.
    Sherer Y; Levy Y; Shoenfeld Y
    Clin Rheumatol; 1999; 18(3):238-40. PubMed ID: 11206350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclosporin rapidly diminished a severe lupus-associated macrophage association syndrome refractory to pulsed methylprednisolone and intravenous immunoglobulin.
    Takizawa Y; Maruyama J; Setoguchi K
    Scand J Rheumatol; 2009; 38(6):492-4. PubMed ID: 19922027
    [No Abstract]   [Full Text] [Related]  

  • 37. Successful IV pulse cyclophosphamide in refractory PM in 3 patients with SLE.
    Kono DH; Klashman DJ; Gilbert RC
    J Rheumatol; 1990 Jul; 17(7):982-3. PubMed ID: 2213771
    [No Abstract]   [Full Text] [Related]  

  • 38. Lupus acute cardiomyopathy is highly responsive to intravenous immunoglobulin treatment: Case series and literature review.
    Meridor K; Shoenfeld Y; Tayer-Shifman O; Levy Y
    Medicine (Baltimore); 2021 May; 100(18):e25591. PubMed ID: 33950936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High dose intravenous immunoglobulin therapy for rheumatic diseases: clinical relevance and personal experience.
    De Vita S; Ferraccioli GF; Di Poi E; Bartoli E; Bombardieri S
    Clin Exp Rheumatol; 1996; 14 Suppl 15():S85-92. PubMed ID: 8828953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute fulminant necrotising lymphocytic myocarditis in a patient with mixed connective tissue disease: a rapid clinical response to immunosuppression.
    Fairley SL; Herron B; Wilson CM; Roberts MJ
    Ulster Med J; 2014 May; 83(2):119-20. PubMed ID: 25075144
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.